Those who have attended the Advanced Diabetes Management Course will be familiar with the idea of applying to WINZ for additional diabetes costs for whānau who are eligible.
While Pharmac is still in consultation regarding the funding of CGM for people living with type 1 diabetes, there will not be funding for those living with type 2.
The Aotearoa Diabetes Collective has created a useful guide, linked below, with templates for letters to support applications for CGM and empagliflozin (for those already prescribed a GLP1ra) for people living with type 2 diabetes.
Contact the diabetes lead in your region if you have further pātai (questions) or would like to set up LibreLink in your practice to be able to access patient data from the sensors.
Kathy joined Pinnacle earlier this month as clinical diabetes specialist for Waikato, replacing the role previously held by Anne Waterman.
Read moreThe Diabetes and Chronic Kidney Disease program aims to slow progression of CKD leading to end-stage renal disease and other diabetes related complications. The aims are achieved by partnering with the patient/whanau, sharing matauranga/knowledge, improving self-management skills and strategies, and enabling appropriate treatment intensification. For people living with suboptimal diabetes (Hbalc greater than 53 mmol/mol) and CKD 3B or earlier (eGFR 30 ml/min and above), please see the referral criteria and pathway for guidance.
Read moreFunding for patients who require a follow-up appointment following HbA1c retest by Awanui Labs.
View detailsA guide for clinical management of type 2 diabetes, to support nurses at all levels to develop their knowledge and clinical reasoning in diabetes care.